2013
DOI: 10.5301/ru.2013.10721
|View full text |Cite
|
Sign up to set email alerts
|

Nephron Sparing Surgery in Renal Cell Carcinoma: Our Experience of a 20-year Clinical Practice

Abstract: Our data show that the implementation of NSS offers long-term benefits in terms of functional results and a good cancer control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Participants in this study had stage IV cancer, meaning the cancer had spread to other organs or lymph nodes where average survival time ranges from 4 months to 5 years, with 8 % expected to live 5 years, depending on cancer type (clear cell, sarcomatoid, papillary) and treatment (chemotherapy, full nephrectomy, partial nephrectomy, etc.) (Dutcher & Nanus 2011; Pace et al 2013; American Cancer Society 2012). Informed consent was obtained from each participant prior to enrollment in the study.…”
Section: Methodsmentioning
confidence: 99%
“…Participants in this study had stage IV cancer, meaning the cancer had spread to other organs or lymph nodes where average survival time ranges from 4 months to 5 years, with 8 % expected to live 5 years, depending on cancer type (clear cell, sarcomatoid, papillary) and treatment (chemotherapy, full nephrectomy, partial nephrectomy, etc.) (Dutcher & Nanus 2011; Pace et al 2013; American Cancer Society 2012). Informed consent was obtained from each participant prior to enrollment in the study.…”
Section: Methodsmentioning
confidence: 99%